DK0563389T3 - Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme - Google Patents

Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme

Info

Publication number
DK0563389T3
DK0563389T3 DK92919013.0T DK92919013T DK0563389T3 DK 0563389 T3 DK0563389 T3 DK 0563389T3 DK 92919013 T DK92919013 T DK 92919013T DK 0563389 T3 DK0563389 T3 DK 0563389T3
Authority
DK
Denmark
Prior art keywords
prophylaxis
treatment
viral diseases
aerosol composition
pharmaceutical aerosol
Prior art date
Application number
DK92919013.0T
Other languages
English (en)
Inventor
Alexandr V Ovcharenko
Oleg Petrovich Zhirnov
Original Assignee
Oleg Petrovich Zhirnov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21584787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0563389(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oleg Petrovich Zhirnov filed Critical Oleg Petrovich Zhirnov
Application granted granted Critical
Publication of DK0563389T3 publication Critical patent/DK0563389T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92919013.0T 1991-08-21 1992-08-19 Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme DK0563389T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU5000531/14A RU2054180C1 (ru) 1991-08-21 1991-08-21 Способ лечения вирусных респираторных инфекций

Publications (1)

Publication Number Publication Date
DK0563389T3 true DK0563389T3 (da) 1996-09-30

Family

ID=21584787

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92919013.0T DK0563389T3 (da) 1991-08-21 1992-08-19 Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme

Country Status (9)

Country Link
US (1) US5723439A (da)
EP (1) EP0563389B1 (da)
JP (1) JP2774379B2 (da)
AT (1) ATE137958T1 (da)
AU (1) AU2517792A (da)
DE (1) DE69210802T2 (da)
DK (1) DK0563389T3 (da)
RU (1) RU2054180C1 (da)
WO (1) WO1993003708A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99864A (en) * 1990-10-31 2000-11-21 Autoimmune Inc Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens
CA2167538A1 (en) * 1993-07-19 1995-02-02 Tsutomu Arakawa Stabilization of aerosolized proteins
NZ331540A (en) 1996-03-11 1999-10-28 Bayer Ag Human bikunin
DE19830694A1 (de) * 1998-07-09 2000-01-13 Bayer Ag Substituierte Acylaminophenyl-uracile
EP1374891B1 (en) * 1998-12-22 2008-09-10 Bayer Aktiengesellschaft Method for accelerating the rate of mucociliary clearance
DE10141749A1 (de) * 2000-08-29 2002-03-14 Max Delbrueck Centrum Mittel zur Beeinflussung der Angiogenese
JP5348651B2 (ja) 2002-11-22 2013-11-20 ネクスバイオ，インク． 広域抗ウイルス治療および予防薬
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US8512710B2 (en) 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
MD3381G2 (ro) * 2006-06-19 2008-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de tratament al parotiditei cronice la copii
EP2371857A1 (en) * 2010-04-01 2011-10-05 CSL Behring GmbH Factor XII inhibitors for treating interstitial lung disease
RU2425691C1 (ru) * 2010-07-15 2011-08-10 ВАКЕ спол с.р.о. Аэрозольный препарат на основе апротинина для лечения вирусных респираторных инфекций
CA2836511C (en) * 2011-06-02 2021-10-19 SOCPRA Sciences Sante et Humaines S.E.C. Matriptase inhibitors and uses thereof against orthomyxoviridae infections
RU2657523C2 (ru) * 2011-11-03 2018-06-14 Олег Петрович Жирнов Фармацевтический аэрозольный состав ингибиторов протеаз с озон-сберегающим пропеллентом и его получение
DE202012013134U1 (de) 2012-11-01 2014-12-05 Oleg Petrovich Zhirnov Pharmazeutische Aerosolformulierung von Protease-Inhibitoren und deren Zubereitung
TWI718086B (zh) 2013-01-07 2021-02-11 英屬維爾京群島商遠東超級實驗室有限公司 通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物
RU2711080C2 (ru) * 2015-06-15 2020-01-15 Олег Петрович Жирнов Комбинированный аэрозольный состав на основе ингибиторов протеаз и его получение
RU2738885C1 (ru) * 2020-04-30 2020-12-18 Андрей Александрович Иващенко Противо-SARS-CoV-2 вирусное средство Антипровир
US20220000993A1 (en) * 2020-07-06 2022-01-06 Torvald Ranta Foretagsjuridik AB Drug for use against the novel coronavirus disease, covid-19
WO2022216172A1 (ru) * 2021-04-06 2022-10-13 Андрей Александрович ИВАЩЕНКО Водная апротинин-содержащая противовирусная фармацевтическая композиция

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556587A (da) * 1957-01-31 1957-04-11
DE2654124A1 (de) * 1976-11-29 1978-06-01 Bayer Ag Derivate des trypsin-kallikrein-inhibitors aus rinderorganen (bpti) mit proteasenhemmwirkung und antiphlogistischer wirkung, ihre herstellung und ihre verwendung als arzneimittel
CA1178889A (en) * 1980-08-28 1984-12-04 Kenneth S. Su Intranasal formulation
EP0068048B1 (de) * 1981-06-25 1985-06-19 Serapharm GmbH & Co. KG Angereichertes Plasmaderivat zur Unterstützung von Wundverschluss und Wundabdeckung
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US5262157A (en) * 1987-03-26 1993-11-16 Sloan-Kettering Institute For Cancer Research Method of preventing Pneumocystis carinii pneumonia using pentamidine in an aerosol form
JP2656944B2 (ja) * 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
FR2646354B1 (fr) * 1989-04-27 1994-06-10 Sanofi Sa Utilisation de peptides inhibiteurs de proteases acides pour la preparation de medicaments utiles pour le traitement de maladies virales
CS275231B2 (en) * 1989-09-29 1992-02-19 Ustav Makormolekularni Chemie Medicine bottle
DE4117078A1 (de) * 1991-05-25 1992-11-26 Boehringer Ingelheim Kg Verfahren zur herstellung therapeutisch anwendbarer aerosole

Also Published As

Publication number Publication date
AU2517792A (en) 1993-03-16
DE69210802T2 (de) 1997-01-16
DE69210802D1 (de) 1996-06-20
EP0563389A1 (en) 1993-10-06
EP0563389A4 (en) 1993-10-20
ATE137958T1 (de) 1996-06-15
EP0563389B1 (en) 1996-05-15
RU2054180C1 (ru) 1996-02-10
WO1993003708A1 (en) 1993-03-04
JPH06506474A (ja) 1994-07-21
JP2774379B2 (ja) 1998-07-09
US5723439A (en) 1998-03-03

Similar Documents

Publication Publication Date Title
DK0563389T3 (da) Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme
ATE128350T1 (de) Pharmazeutische aerosolformulierung.
ATE401093T1 (de) Extrakte, wirkstoffe und pharmazeutische präparate mit antidiabetischen eigenschaften und ihre verwendung
DE3581819D1 (de) Pyridazinamine wirksam gegen viren.
GR3006177T3 (da)
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
MD707B2 (en) Sulphonylurea derivatives, process for their preparation, the intermediate products for them, the herbicide and plants growing suppressing remedy on their base, weeds control process
DE68902531D1 (de) Dispergierbare zubereitung.
KR960014782B1 (en) Benzisothiazolinone 1-dioxide derivatives and elastase inhibitors composition comprising them
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
NO912414L (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
SE8600658D0 (sv) Novel composition of matter
FI962056A0 (fi) Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
DK0533896T3 (da)
ZA857040B (en) Compositions killing or inhibiting the growth of microorganisms and the use thereof
ATE37185T1 (de) Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern.
JPS6456622A (en) Percutaneous absorbefacient base composition
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
DE69808287T2 (de) Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid
JPS5742620A (en) Novel antiulcer agent
JPS54135738A (en) Novel aminobenzoic acid-n-d-mannoside and drugs comprising it
JPS57197220A (en) Muscle relaxant
RU2004235C1 (ru) Способ профилактики острых респираторных болезней тел т
DE69116452D1 (de) Verwendung von 3-Oxygermylpropionsäure zur Behandlung des Erkältungssyndroms